Ubie is a Japanese digital health company founded in 2017 by a physician and an engineer to apply AI to the patient journey, from understanding symptoms to connecting with appropriate care. Its consumer-facing product is an AI symptom checker that lets users describe symptoms, search by disease name or medical specialty, and receive information about possible related conditions and relevant care options. Ubie is careful to position the tool as informational rather than a medical device or diagnosis.
On the provider side, Ubie developed AI-driven medical questionnaire and efficiency tools that help clinics and hospitals streamline intake and reduce administrative burden on physicians. This dual model, serving both patients and healthcare providers, has helped Ubie embed itself across the Japanese healthcare system, where its symptom assessment technology has been used widely. The company emphasizes responsible deployment given the sensitivity and regulation of medical information.
Ubie has increasingly invested in generative AI and provider solutions, and has set its sights on international expansion, particularly into the United States. This US push targets both consumer symptom navigation and tools that support clinicians, reflecting the company's ambition to scale beyond its home market into one of the world's largest healthcare systems.
The company has raised substantial capital, with cumulative funding surpassing $125 million across multiple rounds and more than twenty investors. Notably, Google made its first investment in Ubie in its Series C round in October 2024, alongside backers such as Japan Finance Corporation and The Shoko Chukin Bank. With this funding and the endorsement of major strategic and institutional investors, Ubie is positioned to expand its AI healthcare platform internationally while deepening its role in Japan's medical infrastructure.